New study points to possible cognitive benefits of LSD microdosing


An article published this week sheds new light on the neurological benefits of low doses of LSD in increasing neuroplasticity in the brain.

The new, intra-subject, placebo-controlled study looked at the effect of single low doses of LSD (5, 10, and 20 micrograms) on circulating BDNF levels in healthy volunteers.

The presence of brain-derived neurotropic factor (BDNF) in blood plasma is a queue used to measure levels of neuroplasticity in humans.

While the practice of microdosing psychedelics has received a lot of attention based on anecdotal evidence, there is a significant lack of clinical data proving its benefits beyond the placebo effect.

A recent trial involving 191 participants found that the cognitive benefits of subjects who consumed small doses of LSD were equal to those found in the cohort of patients consuming a placebo.

Research has shown possible links between BDNF levels and conditions such as depression, obsessive-compulsive disorder, Alzheimer’s disease, diabetes, Huntington’s disease, Rett syndrome, dementia, anorexia and bulimia, according to the Beckley Foundation, which co-sponsored the study with Maastricht University in the Netherlands.

Increased levels of BDNF are also associated with improved cognitive functioning and mental health as well as short and long-term memory.

“This study provides preliminary evidence that low doses of LSD increase plasma levels of BDNF in healthy volunteers for up to 6 hours after administration, suggesting a window of opportunity for a therapeutic response and cognitive improvement that may be. useful in patient populations, ”the study reads. .

Photo by Psychonaught on Wikimedia Commons

Source link


Leave A Reply